OXOID LIMITED

1. OXOID LIMITED 1997-01-08 → present
2. PEWTER (NO.2) LIMITED 1996-12-17 → 1997-01-08
3. OXCO (NO 2) LIMITED 1996-12-09 → 1996-12-17

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

PricewaterhouseCoopers LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The company meets its day-to-day working capital requirements through its bank facilities. The current economic conditions continue to create uncertainty over (a) the level of demand for the company's products; and (b) the availability of bank finance for the foreseeable future. The company's forecasts and predictions, taking account of reasonably possible changes in trading performance, show that the company should be able to operate within the level of its current liabilities. After making enquiries, the directors have a reasonable expectation that the company has access to adequate resources to continue in operational existence for a period of at least 12 months from the date of approval of the financial statements. The company therefore continues to adopt the going concern basis in preparing its financial statements. Thermo Fisher Scientific Inc. has indicated its intention to provide any necessary financial support to enable the company to continue in operational existence for a period of at least twelve months from when these financial statements are approved. Thus, the directors believe that it is appropriate for the financial statements to be prepared on the going concern basis.”

Group structure

1. OXOID LIMITED · parent
   1. G & M Procter Limited 100% · United Kingdom · manufacture of pharmaceutical products
   2. Thermo Fisher (Heysham) Limited 100% · United Kingdom · holding entity
   3. Avocado Research Chemicals Limited 100% · United Kingdom · manufacture of chemicals
   4. Oxoid Limited 0% · Ireland · holding entity

Significant events

• “The company is a part of Thermo Fisher Scientific Inc.'s global strategy to reduce our carbon footprint by 30% by 2030.”
• “This entity [Oxoid Limited (Ireland)] was disposed of in 2024 as part of the group's legal entity rationalisation project. The entity was fully liquidated in Q4 2024 and was held at £nil net book value so this has no affect on the values included in the financial statements.”
• “Oxoid Limited have given a deferment bank guarantee in respect of future duty payable. At 31 December 2024 the company guaranteed £6,000,000 (2023: £6,000,000) to HM Revenue and Customs.”
• “There were no adjusting or significant non-adjusting events arising after the financial year.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

3

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  +5.7%

  £153,482,000 → £162,248,000

• Cash

  +20.7%

  £899,000 → £1,085,000

• Net assets

  +6.7%

  £332,229,000 → £354,584,000

• Employees

  0%

  412 → 412

• Operating profit

  +156.4%

  £5,737,000 → £14,708,000

• Profit before tax

  +873.8%

  -£3,381,000 → £26,163,000

• Wages

  -0.8%

  £23,319,000 → £23,144,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers